Cipla (CPLFY) E10: $0.00 (As of Mar. 2026)


What is Cipla E10?

Cipla CPLFY 94 E10 is $0.00 as of Mar. 2026. GuruFocus rates CPLFY with a GF Score™ of 94/100. The stock has 3 warning signs investors should review.

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cipla's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.074. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cipla's average E10 Growth Rate was 10.40% per year. During the past 3 years, the average E10 Growth Rate was 13.20% per year. During the past 5 years, the average E10 Growth Rate was 11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cipla was 13.20% per year. The lowest was 8.20% per year. And the median was 10.40% per year.

As of today (2026-06-26), Cipla's current stock price is $0.00. Cipla's E10 for the quarter that ended in Mar. 2026 was $0.00. Cipla's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Cipla was 53.47. The lowest was 18.31. And the median was 40.20.


Cipla  (OTCPK:CPLFY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Cipla was 53.47. The lowest was 18.31. And the median was 40.20.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cipla E10 Related Terms


Cipla E10 Historical Data

* Premium members only.

The historical data trend for Cipla's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla E10 Chart

Cipla Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cipla Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CPLFY vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cipla's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipla Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cipla's Shiller PE Ratio falls into.



Cipla E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cipla's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.074/164.2724*164.2724
=0.074

Current CPI (Mar. 2026) = 164.2724.

Cipla Quarterly Data

per share eps CPI Adj_EPS
201606 0.063 105.961 0.098
201609 0.066 105.961 0.102
201612 0.069 105.196 0.108
201703 -0.012 105.196 -0.019
201706 0.079 107.109 0.121
201709 0.081 109.021 0.122
201712 0.077 109.404 0.116
201803 0.034 109.786 0.051
201806 0.082 111.317 0.121
201809 0.065 115.142 0.093
201812 0.058 115.142 0.083
201903 0.065 118.202 0.090
201906 0.085 120.880 0.116
201909 0.082 123.175 0.109
201912 0.061 126.235 0.079
202003 0.041 124.705 0.054
202006 0.095 127.000 0.123
202009 0.112 130.118 0.141
202012 0.126 130.889 0.158
202103 0.070 131.771 0.087
202106 0.120 134.084 0.147
202109 0.120 135.847 0.145
202112 0.120 138.161 0.143
202203 0.059 138.822 0.070
202206 0.109 142.347 0.126
202209 0.122 144.661 0.139
202212 0.120 145.763 0.135
202303 0.079 146.865 0.088
202306 0.150 150.280 0.164
202309 0.169 151.492 0.183
202312 0.157 152.924 0.169
202403 0.140 153.035 0.150
202406 0.175 155.789 0.185
202409 0.192 157.882 0.200
202412 0.229 158.323 0.238
202503 0.175 157.552 0.182
202506 0.187 159.755 0.192
202509 0.189 162.289 0.191
202512 0.093 163.281 0.094
202603 0.074 164.272 0.074

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.00 mean?
Cipla (CPLFY) has a E10 of $0.00 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cipla and its competitors.
Is Cipla's E10 too high?
Cipla's current E10 is $0.00. Overall, Cipla has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Cipla's E10 compare to ZTS?
Cipla's E10 of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cipla and its competitors. Cipla's current E10 is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Cipla (CPLFY) has a current E10 of $0.00. The current E10 is $0.00. Cipla's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Cipla (CPLFY), the current E10 is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cipla Business Description

Other Exchanges CIPLA:India500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.